EcoDrugPlus

Retinoid X Receptor Beta

Ensembl ID : ENSODEG00000017146
Gene Symbol: RXRB
3 Cross references
234 Possible Orthologues:

Retinoid X Receptor Gamma

Ensembl ID : ENSODEG00000007429
Gene Symbol: RXRG
3 Cross references
273 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSODEG00000016699
Gene Symbol: RPL10A
3 Cross references
203 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSODEG00000014876
Gene Symbol: RPL11
3 Cross references
170 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSODEG00000017416
Gene Symbol: RPL18
1 Cross references
233 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSODEG00000010475
Gene Symbol: RPL22
2 Cross references
23 Possible Orthologues:

Ribosomal Protein L27

Ensembl ID : ENSODEG00000018089
Gene Symbol: RPL27
3 Cross references
196 Possible Orthologues:

Ribosomal Protein L28

Ensembl ID : ENSODEG00000010391
Gene Symbol: RPL28
2 Cross references
200 Possible Orthologues:

Ribosomal Protein L36

Ensembl ID : ENSODEG00000020089
Gene Symbol: RPL36
2 Cross references
120 Possible Orthologues:

Ribosomal Protein L36

Ensembl ID : ENSODEG00000019330
Gene Symbol: RPL36
2 Cross references
106 Possible Orthologues:

Ribosomal Protein L37

Ensembl ID : ENSODEG00000002946
Gene Symbol: RPL37
2 Cross references
99 Possible Orthologues:

Ribosomal Protein S10

Ensembl ID : ENSODEG00000017159
Gene Symbol: RPS10
2 Cross references
288 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).